White House COVID-19 Response Team Briefing (LIVE) | USA TODAY

1 917
Published on 26 Feb 2021, 16:49
The White House COVID-19 Response Team and public health officials deliver remarks as a federal advisory panel reviews the Johnson & Johnson vaccine.

RELATED: bit.ly/37PzIKO

Roughly 45 million Americans have received coronavirus vaccines since mid-December, but many, many more are eagerly awaiting access.

Johnson & Johnson's version, which requires just one shot, is on track to become third vaccine allowed for use in U.S.

The Vaccines and Related Biological Products Advisory Committee, is expected to recommend J&J's shot for use in adults, on Friday.

An emergency use authorization from the acting commissioner of the Food and Drug Administration is anticipated to follow within days.

» Subscribe to USA TODAY: bit.ly/1xa3XAh
» Watch more on this and other topics from USA TODAY: bit.ly/3qZLoBV
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.